Ranbaxy Laboratories' stock price has reeled under the pressure of regulatory bans imposed by the US drug regulator on its manufacturing facilities.
Britannia’s profitability suffered during the June 2010 quarter even though its topline continued to grow in double digits.
Nestle India has weathered a challenging environment of high agro-commodity prices and food inflation during the June ’10 quarter.
The Pfizer stock has offered better returns to investors than the Bombay Stock Exchange’s (BSE) benchmark index, the Sensex, over the past one month.
The battle for Parkway is getting increasingly competitive as the two players — Fortis Healthcare and Khazanah — struggle to out-bid each other.
The stock of Hyderabad-based Natco Pharma has earned impressive returns over the past six months compared with the gains in broader market indices.
Piramal Healthcare has announced plans to acquire assets of Canada-based BioSyntech for around Rs 17.48 crore.
The Delhi-based FMCG major Dabur India announced the formal merger of Fem Care Pharma with itself on Monday.
Cipla’s latest move to grow through acquisitions comes at a time when the company has been growing at lower than the industry growth rate for the past few years.
The shareholders of Eveready Industries can look forward to better days ahead. The Kolkata-based manufacturer of dry cell batteries and flashlights seems to have finally put the ghost of the past behind.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon